Veru (VERU) Long-Term Investments (2023 - 2024)

Veru (VERU) posted quarterly Long-Term Investments of $228824.0 for Q2 2024, down 33.95% quarter-over-quarter from $346444.0 in Q1 2024.

Veru (VERU) Long-Term Investments (2023 - 2024) Analysis & Trends

Veru (VERU) has reported Long-Term Investments for 2 consecutive years, with $228824.0 the latest figure, recorded in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	5.79 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	9.83 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	1.77 Bn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	22.17 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	372.10 Mn
10	Veru	60.85 Mn	35.06 Mn	-	-

Download Data